Latest GHIAA News
Latest GHIAA News
- GHIAA calls for CSO Access to Pandemic Agreement Negotiations (July 13, 2024) - Along with 140 supporters form 40 different countries, GHIAA has signed on to Pandemic Action Network’s Partner Call for Action. The open letter demands the official inclusion of civil society organizations (CSOs) in the INB Pandemic Agreement negotiation process Read the full letter and sign here.
- Jule to Speak at Conference on Resolving Vaccine Equity (April 10, 2024) - Julie is an invited speaker at the British Academy Conference on Resolving Vaccine Inequity. Hosted at the SOAS University of London from April 11-12, this year’s conference theme is Resolving Global Vaccine Inequality: Innovation, Capabilities and Governance. Julie will be speaking during the “Vaccine Nationalism, Vaccine Inequity, Production and IPR” session starting at 1:30pm BST on April 11 and will specifically address intellectual property rights, pharma product licensing, and global public health security. Register and learn more.
- Ongoing Review of the Pandemic Accord (March 27, 2024) - GHIAA has published comprehensive comments and recommendations regarding the most recent negotiating texts for the Pandemic Agreement. Read Our Commentary Here
- GHIAA to Participate in Salzburg Global Seminar (March 6, 2024) - Julie will be participating in the Salzburg Global Seminar’s event, “Better Preparedness for the Next Pandemic: Developing Vaccine Access Models with Low- and Middle- Income Countries” from March 11- 16. Targeted outcomes of the event include establishing key principles in the design of a new mechanism for global counter-measures, which could be brought forward to international decision takers, and providing a narrative record to capture practical insights that informed this design of next-generation multilateral procurement mechanisms for pandemics and outbreaks. Learn more about the program here.
- GHIAA Releases the Equitable Access Glossary (November 27, 2023) - GHIAA is pleased to share The Equitable Access Glossary, a new tool designed to help a variety of stakeholders understand commonly used terms in the development, negotiation, and implementation of policies and agreements that aim to support equitable access to medical products. Access the Glossary Here.
- Julia Barnes-Weise to Join Panel on Licensing and Funding Healthcare Innovations for Global Impact (September 5, 2023) - Julie also will speak at the Licensing Executives Society (U.S.A. and Canada), Inc. Annual Meeting, which will be held October 15-18 in Chicago. The meeting brings together licensing and intellectual property (IP) professionals and the program focuses on the latest trends, advancements, and best practices in licensing and intellectual capital management. Julie will participate in a workshop called Licensing and Funding Healthcare Innovations for Global Impact with Chan Park of the Medicines Patent Pool, Lauren Sullivan of the Bill & Melinda Gates Foundation, and Emmy Wheatley of CEPI (Coalition for Epidemic Preparedness Innovations). Registration is Open
- GHIAA ED Scheduled for Panel at National Vaccine Law Conference. (September 4, 2023) - Julie will be part of a panel on Equity Throughout the Global Vaccine Lifecycle at the National Vaccine Law Conference in Washington D.C., on September 14-15. Registration is available for both in-person and virtual options. Learn More and Register
- Executive Director Julia Barnes-Weise to Speak at Disease Prevention and Control Summit (September 3, 2023) - Our executive director Julia Barnes-Weise will be speaking about partnering & planning for equitable access to vaccines on Day 2 of the Disease Prevention and Control Summit in Philadelphia, September 8, 2023. Register here
- GHIAA ED Authors New Article (May 30, 2023) - Julia Barnes-Weise, Colin N. O'Leary, Kendall Hoyt, and Margaret Bourdeaux have penned a new article titled "Maintaining Warp Speed: Policy Requirements for a Just-in-Time, Capability-Based, Scalable Medical Countermeasure Research and Development Enterprise," published in Health Security. Read More
- Article Published in BMJ (April 10, 2023) - We're pleased to share that our letter, "Public investment in the development of vaccines: providing equitable access around the world," has been published in BMJ. Read It Here
- GHIAA Announces New Equitable Access Toolkit (December 12, 2022) - GHIAA is pleased to announce the release of the Equitable Access Toolkit, a resource designed to support medical product R&D funders with the translation of equitable access policies into funding agreement provisions that have meaningful and measurable impact. Explore the toolkit here.
- GHIAA ED Julia Barnes-Weise to Participate in Panel Hosted By NUS (November 23, 2022) - Hosted by the Center for International Law at the National University of Singapore, the panel entitled “𝗔𝗱𝘃𝗮𝗻𝗰𝗶𝗻𝗴 𝗚𝗹𝗼𝗯𝗮𝗹 𝗘𝗾𝘂𝗶𝘁𝗮𝗯𝗹𝗲 𝗔𝗰𝗰𝗲𝘀𝘀 𝘁𝗼 𝗩𝗮𝗰𝗰𝗶𝗻𝗲𝘀: 𝗜𝗻𝘁𝗲𝗹𝗹𝗲𝗰𝘁𝘂𝗮𝗹 𝗣𝗿𝗼𝗽𝗲𝗿𝘁𝘆, 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆 𝗧𝗿𝗮𝗻𝘀𝗳𝗲𝗿 𝗮𝗻𝗱 𝗖𝗼𝗻𝘁𝗿𝗮𝗰𝘁𝘀” will be live at 1pm, Singapore time. A recording will be available afterwards for those unable to join in real-time. Learn More and Register
- Board Member to Present at WIPF (September 13, 2022) - GHIAA Board member Ana Santos Rutschman will be presenting “The Role of Intellectual Property in Achieving Global Health Security” at the World Intellectual Property Forum in Bangkok on October 12, 2022, 9:00am local time. Read More
- Julie Barnes-Weise to present at LES Annual Meeting (September 12, 2022) - On October 18, 2022 at 2:15 PST, Julie will be participating in a session at the Licensing Executives Society (U.S.A. and Canada), Inc. (LES) Annual Meeting entitled, “Working with Funders and International Organizations to Access Non-Traditional Global Markets.” Full Agenda Here
- GHIAA ED to Speak at Harvard Law (August 30, 2022) - Julie has been invited to speak at Harvard Law School’s Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics in a panel titled, “Creating Sustainable Infrastructure for Pandemic Preparedness and Response“ along with participants from The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, the Harvard University Kennedy School of Government, Ginkgo Bioworks, Inc., and University of Massachusetts Lowell. This is a virtual event taking place at 12:30 EDT on September 14, 2022, and registration is currently open. Register Here
- New Article in Think Global Health: Building COVID-19 Vaccine Production Capacity in LMICs (May 26, 2022) - Authors Reid Adler, Julia Barnes-Weise, Ana Santos Rutschman, and Bridie Telford have published a new article in Think Global Health exploring the potential obstacles created by vaccine patents. The piece includes a table listing the LMICs in which there are active patent filings for the 13 vaccines tracked in VaxPaL, the Medicines Patent Pool on-line database of information on the patent status of COVID-19 vaccines worldwide. Read More
- MAPGuide Featured in New "Inventory of COVID-19 Information Resources" (March 31, 2022) - Compiled by the World Trade Organization, this resource provides information on a variety of topics, such as vaccination, production of vaccines, government procurement, cases, diagnostics, therapeutics and intellectual property-related issues from NGOs, IGOS, academics, nonprofits, and the private sector. The inventory will be updated as new resources become available. Access the Inventory
- GHIAA Participates in Vaccine Equity Conference with Columbia University (March 18, 2022) - On Wednesday, March 30 at 12pm EST, GHIAA Executive Director Julie Barnes-Weise will participate in a roundtable discussion titled "Vaccine Equity Distribution Capacity-Building in terms of IP, Technology and Talent Transfer, and Manufacturing." The roundtable is part of a 4-day symposium on Covid-19 vaccines hosted by the Columbia University Irving Medical Center. This symposium is free and virtual, with registration required. Register Here
- Panel Participation (February 25, 2022) - The global intellectual property framework has been instrumental to developing Covid vaccines, with billions of doses now made every month. Following our recent paper assessing the proposed intellectual property waiver as a mechanism to address COVID-19 vaccine scarcity, GHIAA Executive Director, Julie Barnes-Weise will participate in a panel hosted by the Geneva Network on March 2. Register Here
- Upcoming Joint Webinar with WTO, WIPO, and WHO (February 20, 2022) - On February 28, 2022, GHIAA Executive Director Julia Barnes-Weise will be discussing the MAPGuide as part of a virtual workshop on COVID-19 related information resources. This is the second in a series of workshops aimed at strengthening the capacity of policymakers across the WTO, WIPO, and WHO. Register Here
- New Commentary in The Journal of Epidemiology & Community Health (February 13, 2022) - The idea for temporary IP waivers to facilitate the development of urgently-needed vaccines has gained recent traction in the global health world. In our latest commentary for the Journal of Epidemiology and Community Health, authors Julia Barnes-Weise, Ana Santos Rutschman, and Reid Adler discuss why IP waivers are an imperfect solution to the supply problem- and what should be improved upon instead. Read Article
- Jaharis Law Presentation (April 30, 2021) - GHIAA Executive Director Julie Barnes-Wise spoke at the Mary and Michael Jaharis Health Law Institute Annual Symposium on Thursday April 29th, 2021. Her presentation discussed the role of step-in rights and technology transfer in relation to equitable access to vaccinations amidst the COVID-19 pandemic. Read More
- STAT article: the need for the MAPGuide (April 1, 2021) - Global healthcare partners will benefit from a shareable repository of contracts to address key issues in global health research, development, and purchasing. A glossary informs stakeholders about alternate definitions of key terms to prepare parties for negotiations and to give them a common language for discussion. Read Article
- Promoting Innovation Where Market Incentives Do Not Work (March 10, 2021) - Supporting the development of innovative health products is not only important in the fields of orphan drugs and neglected tropical diseases but also for pandemic preparedness. Our Executive Director, Julie Barnes-Weise, has contributed to this article about how such development can be supported and created an interesting chart setting out how public funding incentives are balanced by the concerns of different types of developers. This article was originally published by Licensing Executives Society International. Read Article
- Katrine Thor Andersen Joins GHIAA’s Board of Directors (March 8, 2021) - The Global Health Innovation Alliance Accelerator (GHIAA) is pleased to announce the appointment of Katrine Thor Andersen to its Board of Directors. Read More
- Glossary of Global Health Agreement Terms (December 1, 2020) - GHIAA is pleased to announce the publication of its Glossary of Global Health Agreement Terms - a curated collection of often used terms in policies, negotiations and agreements in the global public health field. Our continuing goal is to facilitate the discussions which lead to successful global health transactions and alliances. GHIAA welcomes suggestions of new terms and definitions which are important to the global health policy and transactions community. Read More
- New grant from the Wellcome Trust (August 25, 2020) - We are pleased to announce a new grant from the Wellcome Trust to support further development of the MAPGuideⓇ. Read More
- Launch of the MAPGuideⓇ (August 11, 2020) - The GHIAA MAPGuideⓇ is now available for public use. We look forward to receiving user feedback as well as additional agreements and provisions to include in the MAPGuideⓇ. Read More
- COVID-19 agreements (August 10, 2020) - GHIAA is tracking new agreements arising from the development of COVID-19 diagnostics, therapeutics and vaccines with the aim of including COVID-19 agreements in the MAPGuideⓇ. GHIAA also recently provided input to an article published in Science on the importance of knowledge transfer for large-scale vaccine manufacturing in the context of COVID-19. See COVID-19 Agreements in the MAPGuide.
- Wellcome Trust grant (November 18, 2019) - GHIAA is excited to announce that it is receiving support from the Wellcome Trust to further develop its online Master Alliance Provisions Guide (MAPGuideⓇ), accelerating the introduction of life-saving global health technologies by streamlining the formation of research and development alliances. Read More